BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ox.ac.uk//NONSGML oxford.event//EN
X-WR-TIMEZONE:Europe/London
BEGIN:VTIMEZONE
TZID:Europe/London
X-LIC-LOCATION:Europe/London
BEGIN:DAYLIGHT
DTSTART:19700329T010000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3
TZNAME:BST
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
END:DAYLIGHT
BEGIN:STANDARD
DTSTART:19701025T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10
TZNAME:GMT
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
SUMMARY:IDEU Seminar - Optimising the prevention of pneumococcal infection
  in children and adults
DTSTART;TZID=Europe/London:20260601T130000
DTEND;TZID=Europe/London:20260601T140000
DTSTAMP:20260515T141651Z
UID:cda7afa0-6c19-f111-8342-7c1e527a0d5f
CREATED:20260306T145647Z
DESCRIPTION:"David Goldblatt    \nInfection\, Immunity and Inflammation De
 partment\, Great Ormond Street Institute of Child Health\, University Coll
 ege London\nand\nGreat Ormond Street Children’s Hospital NHS Foundation 
 Trust\n\n\nDavid Goldblatt is Professor of Vaccinology and Immunology at t
 he Great Ormond Street Institute of Child Health\, University College Lond
 on (UCL) and a Consultant Paediatric Immunologist at the Great Ormond Stre
 et Hospital for Children NHS Foundation Trust. He obtained his medical deg
 ree from the University of Cape Town\, South Africa\, a PhD in Immunology 
 from the University of London\, United Kingdom and is a Fellow of the Roya
 l College of Paediatrics and Child Health and Academia Europae. He is an E
 meritus National Institute for Health Research (NIHR) Senior Investigator.
 \nHe has a long-standing interest in the immune response to vaccines and i
 nfectious diseases. He has active research programmes exploring immunity t
 o colonisation/ carriage and infection\, correlates of protection and asse
 ssing alternative vaccines schedules.  His laboratory (a WHO Reference Lab
 oratory for Pneumococcal Serology) interests include Streptococcus Pneumon
 iae\, Klebsiella Pneumonia\, Group A and B Streptococcus and SARS-CoV-2. H
 e is an advisor to the World Health Organisation (WHO) on vaccine schedule
 s and Klebsiella Pneumoniae vaccines and chairs the WHO Technical Advisory
  Group on Group B Streptococcus vaccines. He serves on subcommittees of th
 e United Kingdom Department of Health Joint Committee on Vaccines and Immu
 nisation (JCVI) and advised the MHRA on COVID Vaccine licensure via member
 ship of the Commission on Human Medicines COVID-19 Vaccines Benefit Risk E
 xpert Working Group. He chairs several Scientific Advisory Boards includin
 g the International SAB advising the Malawi-Liverpool-Wellcome Trust Clini
 cal Research Programme in Blantyre. He is currently secretary of the Inter
 national Society of Pneumonia and Pneumococcal Disease having served as Pr
 esident from 2018 to 2024."
LAST-MODIFIED:20260508T082522Z
LOCATION:Big Data Institute - Seminar rooms\, Seminar rooms Big Data Insti
 tute Old Road Campus Oxford Oxfordshire OX3 7LF United Kingdom
SPEAKER:Professor David Goldblatt
END:VEVENT
END:VCALENDAR